Targeting the Host Adenosine A2A Receptor to Protect Against Fatal Rickettsiosis Using an Approved Parkinson's Disease Drug

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/184/30/21

Funding

  • National Inst of Allergy & Infectious Di: $439,958.00